Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Overview of attention for article published in Journal of Clinical Investigation, July 2015
Altmetric Attention Score: 53
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (90th percentile)
Mentioned by
- news
- 5 news outlets
- 13 X users
- patent
- 11 patents
- 6 Facebook pages
- 1 Redditor
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 205 Mendeley